ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CARM Carisma Therapeutics Inc

1.4903
0.0103 (0.70%)
Pre Market
Last Updated: 08:46:41
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Carisma Therapeutics Inc CARM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0103 0.70% 1.4903 08:46:41
Open Price Low Price High Price Close Price Prev Close
1.48
more quote information »

Recent News

Date Time Source Heading
5/14/20247:00IHNWFeaturedElement79 Gold Corp Reports Exceptionally High-Grade Results from Lucero
5/09/202407:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202407:41EDGAR2Form 8-K - Current report
5/09/202407:30PRNUSCarisma Therapeutics Reports First Quarter 2024 Financial..
5/08/202411:45BWCarmila: Withdrawal of funds for the liquidity contract
5/08/202407:30PRNUSCarisma Therapeutics Presents Preclinical Proof of Concept..
5/07/202411:45BWCARMILA: Information Concerning the Total Number of Voting..
5/06/202407:30PRNUSCarisma Therapeutics to Participate in The Citizens JMP Life..
5/02/202407:30PRNUSCarisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief..
4/24/202417:05PRNUSCarisma Therapeutics Announces Upcoming Presentation at the..
4/24/202412:43BWCarmila : Lancement d’un programme de rachat d’actions pour..
4/22/202416:35PRNUSCarisma Therapeutics to Present New Data at the American..
4/17/202411:45BWCarmila: First-quarter 2024 Financial Information
4/05/202411:45BWCarmila : Informations relatives au nombre total de droits..
4/03/202407:00PRNUSCarisma Therapeutics to Present at Upcoming Conferences
4/01/202408:35PRNUSCarisma Therapeutics Provides Business Update and Reports..
4/01/202407:00PRNUSCarisma Therapeutics Announces Changes to its Board of..
3/21/202417:00PRNUSCarisma Announces Upcoming Presentations at the American..
3/15/202412:45BWCarmila: Filing of the 2023 Universal Registration Document
3/08/202411:45BWCORRECTING and REPLACING: Carmila: Changes in the..
3/07/202416:05EDGAR2Form SC 13D/A - General statement of acquisition of..
3/07/202413:13BWCARMILA: Changes in the composition of the Board of..
3/04/202411:45BWCarmila : Informations relatives au nombre total de droits..
2/28/202407:30PRNUSCarisma Therapeutics to Participate in TD Cowen's 44th..
2/13/202411:45BWCarmila: 2023 Annual Results
2/02/202416:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202413:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/02/202411:45BWCARMILA: Information Concerning the Total Number of Voting..
1/16/202411:45BWCarmila: Resources Devoted to the Liquidity Contract as of..
1/08/202411:57BWCARMILA: Information Concerning the Total Number of Voting..
12/21/202307:00PRNUSCarisma Therapeutics to Present at the 42nd Annual J.P...
12/14/202307:00PRNUSFirst In Vivo CAR-M Lead Candidate Nominated Under..
12/05/202311:45BWCarmila : Informations relatives au nombre total de droits..
11/28/202307:00PRNUSCarisma Therapeutics Announces FDA Clearance of IND..
11/22/202307:30PRNUSCarisma Therapeutics to Participate in Evercore ISI..
11/10/202314:17BWCarmila: Termination of Liquidity Contract With BNP Paribas..
11/09/202311:45BWCARMILA: Information Concerning the Total Number of Voting..
11/09/202308:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202307:42EDGAR2Form 8-K - Current report
11/09/202307:30PRNUSCarisma Therapeutics Reports Third Quarter 2023 Financial..
10/31/202309:25PRNUSCarisma Presents Pre-Clinical Proof of Concept for in vivo..
10/25/202309:11PRNUSCarisma to Present First Results From in vivo CAR-M..
10/20/202311:47BWCarmila: Financial Information as of 30 September 2023
10/02/202312:35BWCarmila : Emission d’un emprunt obligataire de 500 millions..
10/02/202311:45BWCARMILA : Informations relatives au nombre total de droits..
9/05/202308:30PRNUSCarisma Therapeutics to Present at Upcoming Investor..
9/01/202311:45BWCARMILA : Informations relatives au nombre total de droits..
9/01/202309:05EDGAR2Form 8-K - Current report
9/01/202308:30PRNUSCarisma Announces Latest Data from Phase 1 Clinical Trial of..
8/24/202308:30PRNUSCarisma Therapeutics to Present at Upcoming Healthcare..
8/10/202313:44PRNUSCarisma Therapeutics Reports Second Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock